Detalles de la búsqueda
1.
Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01).
Ann Oncol
; 35(3): 302-307, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38092229
2.
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3.
Ann Oncol
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38729566
3.
Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study.
Ann Oncol
; 34(7): 569-577, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37179020
4.
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis.
Ann Oncol
; 32(8): 983-993, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272041
5.
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1.
Ann Oncol
; 32(2): 208-217, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33246021
6.
Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer.
Ann Oncol
; 31(5): 582-589, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32178964
7.
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer.
Ann Oncol
; 31(8): 1001-1010, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32416251
8.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Ann Oncol
; 31(4): 451-469, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32081575
9.
Resveratrol treatment increases mitochondrial biogenesis and improves viability of porcine germinal-vesicle stage vitrified-warmed oocytes.
Cryobiology
; 93: 37-43, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32171796
10.
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study.
Ann Oncol
; 30(3): 405-411, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30475947
11.
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.
Ann Oncol
; 30(3): 397-404, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30475950
12.
Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.
Ann Oncol
; 30(4): 567-574, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30689703
13.
Clinical and immunological features of pemphigus relapse.
Br J Dermatol
; 180(6): 1498-1505, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30585310
14.
CT and MRI characteristics for differentiating mediastinal Müllerian cysts from bronchogenic cysts.
Clin Radiol
; 74(12): 976.e19-976.e25, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31551148
15.
Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
J Eur Acad Dermatol Venereol
; 33(3): 595-600, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30394605
16.
Efficiency of genomic selection for breeding population design and phenotype prediction in tomato.
Heredity (Edinb)
; 118(2): 202-209, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27624117
17.
A case of aplasia cutis congenita type VII with tibial dysplasia.
Clin Exp Dermatol
; 47(2): 412-413, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407227
18.
A genetic analysis of meat compositions in Japanese Black cattle: Genetic parameters and sex influence.
J Anim Breed Genet
; 134(5): 373-382, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28470817
19.
Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial.
Ann Oncol
; 27(6): 1047-1054, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27029704
20.
Corrigendum to 'First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis': Annals of Oncology 2021; 32: 983-993.
Ann Oncol
; 32(12): 1650, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34740469